Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2006. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Is a | trouble causé par un médicament | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | Drug | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Is a | complication | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | Pharmaceutical / biologic product (product) | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | Drug, medicament or biological substance | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | Pharmaceutical / biologic product (product) | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Is a | reazione avversa causata da sostanza | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | Substance | false | Inferred relationship | Some | ||
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Causative agent (attribute) | A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. | true | Inferred relationship | Some | 1 | |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Is a | Adverse reaction (disorder) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Adverse reaction to bromine compounds NOS | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to other vaccines and biological substances | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to drug NOS | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Anesthetics adverse reaction (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Allergic reaction to nickel | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse cutaneous reaction caused by aromatherapy | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug-induced retinopathy | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Analgesic adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to antipyretic | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Allergic reaction to nickel | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Tryptophan adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Radiopharmaceutical adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Lindane adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
réaction indésirable à un antidiabétique | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Ear wax removal preparation adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Hot flash caused by medication | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Intravenous nutrition (amino acids) adverse reaction (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction caused by drug or medicament administered by infusion | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Dimethyl-ether propane adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Phosphodiesterase inhibitor adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Sulfonamide adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Non-allergic anaphylaxis caused by drug | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse drug reaction resulting from treatment of disorder | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Liquid paraffin adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to salicylate | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to antirheumatic | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Smooth muscle relaxant adverse reaction (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Gamolenic acid adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Para-aminophenol derivative adverse reaction (disorder) | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Xanthine adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Sodium nitrite adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Sodium thiosulfate adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to anterior pituitary hormone | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to posterior pituitary hormones | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
pustoloderma tossico farmaco-indotto | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
A drug hypersensitivity reaction with a relatively long latency period after exposure characterized by rash, fever, lymphadenopathy, hematologic abnormalities including eosinophilia and atypical lymphocytosis and internal organ involvement. Clinical presentation is highly variable. Eosinophilia is present in 50-90% of cases. | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Eczematous drug eruption | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Aldehyde dehydrogenase inhibitor adverse reaction (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Pulmonary toxicity | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to mast cell stabilizer (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to oral contraceptive | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
5-HT3-receptor antagonist adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Sulphur adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Emollient adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Dusting powders adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Sunscreening preparations adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Counter irritants adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antidote adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Calcium-channel blocker adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Lipid-lowering drug adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antiarrhythmic drug adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Diuretic adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antihypertensive adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Cardiac inotropic agent adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antivaricose agent adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to digestant | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to emetic | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to lipotropic drugs | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Ulcer healing drug adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antacid adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Motility stimulant adverse reaction (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Laxative adverse reaction (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Bile agent adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antidiarrheal drug adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antiemetic adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction caused by antipruritic (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Retinoid adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Serotonin syndrome (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to hallucinogen | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Centrally acting appetite suppressant adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antidepressant drug adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antiepileptic adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Thiethylperazine adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Central stimulant adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to antiparkinsonism drug | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to barbiturate | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction caused by antiasthmatic (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Respiratory stimulant adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Respiratory surfactant adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Cough suppressant adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Bronchodilator preparations adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction caused by decongestant (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to expectorant | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to skeletal muscle relaxants | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Drug for the treatment of gout adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to anticoagulant antagonists | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Blood derivative adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Anticoagulant adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Haemostatic adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Alpha-adrenoceptor blocking drug adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Parasympathomimetic adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Sympathomimetic adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Anticholinergic adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adrenergic neurone blocking drug adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Allopurinol adverse reaction (disorder) | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Antispasmodic adverse reaction | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to fibrinolytic drugs | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Neuroleptic adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Adverse reaction to central nervous system muscle-tone depressants | Is a | True | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Sedative adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some | |
Nicotine adverse reaction | Is a | False | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | Inferred relationship | Some |
This concept is not in any reference sets